Jennison Associates
ELV icon

Jennison Associates’s Elevance Health ELV Stock Holding History

Jennison Associates’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,420
Closed -$2.13M – 620
2022
Q2 		$2.13M Buy
+4,420
New +$2.19M ﹤0.01% 460
2021
Q1 		– Sell
-149,002
Closed -$47.8M – 685
2020
Q4 		$47.8M Buy
149,002
+50,862
+52% +$15.6M 0.03% 213
2020
Q3 		$26.4M Buy
98,140
+507
+0.5% +$136K 0.02% 277
2020
Q2 		$25.7M Sell
97,633
-40,293
-29% -$10.7M 0.02% 258
2020
Q1 		$31.3M Buy
137,926
+1,198
+0.9% +$326K 0.04% 195
2019
Q4 		$41.3M Buy
136,728
+1,518
+1% +$418K 0.04% 208
2019
Q3 		$32.5M Sell
135,210
-80,589
-37% -$22.1M 0.03% 247
2019
Q2 		$60.9M Buy
215,799
+24,638
+13% +$6.73M 0.06% 177
2019
Q1 		$54.9M Buy
191,161
+28
+0% +$8.1K 0.05% 208
2018
Q4 		$50.2M Buy
191,133
+1,994
+1% +$548K 0.06% 205
2018
Q3 		$51.8M Buy
+189,139
New +$49.1M 0.05% 250
2017
Q3 		– Sell
-15,005
Closed -$2.82M – 669
2017
Q2 		$2.82M Sell
15,005
-2,567
-15% -$461K ﹤0.01% 525
2017
Q1 		$2.91M Sell
17,572
-875
-5% -$139K ﹤0.01% 526
2016
Q4 		$2.65M Sell
18,447
-7,641
-29% -$1.02M ﹤0.01% 538
2016
Q3 		$3.27M Buy
26,088
+1,973
+8% +$255K ﹤0.01% 530
2016
Q2 		$3.17M Buy
24,115
+517
+2% +$70.7K ﹤0.01% 521
2016
Q1 		$3.28M Sell
23,598
-2,297
-9% -$307K ﹤0.01% 507
2015
Q4 		$3.61M Buy
25,895
+1,879
+8% +$259K ﹤0.01% 528
2015
Q3 		$3.36M Buy
+24,016
New +$3.61M ﹤0.01% 560
2013
Q3 		– Sell
-37,519
Closed -$3.07M – 695
2013
Q2 		$3.07M Buy
+37,519
New +$2.81M ﹤0.01% 508

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Jennison Associates's ELV Position: Q3 2022 in Review

Jennison Associates sold out of Elevance Health (ELV) in Q3 2022, closing a stake of 4,420 shares — an estimated $2.13M sold.

Jennison Associates first reported a position in ELV in Q2 2013 and held it in 20 quarters. The position peaked at $60.9M in Q2 2019. 1,447 funds tracked by Wall St. Rank hold ELV as of Q3 2022.

  • Jennison Associates reported no remaining Elevance Health position as of Q3 2022 after selling out during the quarter.
  • Jennison Associates sold 4,420 Elevance Health shares in Q3 2022, an estimated $2.13M.
  • Jennison Associates first reported a position in Elevance Health in Q2 2013 and held it in 20 quarters.
  • Jennison Associates's Elevance Health position peaked at $60.9M in Q2 2019.
  • 1,447 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.

Based on Jennison Associates's 13F filing for Q3 2022, filed 1 Nov 2022.